Compare GEMI & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GEMI | CERT |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Retail: Computer Software & Peripheral Equipment |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2025 | 2020 |
| Metric | GEMI | CERT |
|---|---|---|
| Price | $10.23 | $8.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 9 |
| Target Price | ★ $21.22 | $13.25 |
| AVG Volume (30 Days) | ★ 2.5M | 2.1M |
| Earning Date | 02-15-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | $162,529,000.00 | ★ $415,551,000.00 |
| Revenue This Year | $23.92 | $10.80 |
| Revenue Next Year | $93.28 | $6.47 |
| P/E Ratio | ★ N/A | $130.24 |
| Revenue Growth | ★ 65.61 | 11.47 |
| 52 Week Low | $9.67 | $8.03 |
| 52 Week High | $45.89 | $15.69 |
| Indicator | GEMI | CERT |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 42.45 |
| Support Level | N/A | $8.71 |
| Resistance Level | N/A | $8.94 |
| Average True Range (ATR) | 0.00 | 0.27 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 0.00 | 43.11 |
Gemini Space Station Inc is engaged on unlocking the next era of financial, creative, and personal freedom. It envisions a future where crypto will redesign the global financial system, the internet, and money in a way that provides greater choice, independence, and opportunity for all. As a trusted bridge between the traditional financial system and the emerging crypto economy, It is providing access for individuals and institutions to a decentralized future that is more open, fair, and secure. Its core exchange product has expanded over time to become a comprehensive platform for its users to engage with the crypto economy, including a derivatives exchange, staking services, an over-the-counter (OTC) trading desk, institutional-grade custody, and others.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.